Abstract:Serratia marcescens is an opportunistic human pathogen that causes urinary tract infections, ocular lens infections, and respiratory tract infections. S. marcescens employs various defense mechanisms to evade antibiotics, one of which is mediated by aminoglycoside N -acetyltransferase (AAC). In this mechanism, the enzyme AAC facilitates the transfer and linkage of the acetyl moiety from the donor substrate acetyl-coenzyme A to specific positions on antibiotics. This modification alters the antibiotic's structure, leading to the inactivation of aminoglycoside antibiotics. In the current scenario, antibiotic resistance has become a global threat, and targeting the enzymes that mediate resistance is considered crucial to combat this issue. The study aimed to address the increasing global threat of antibiotic resistance in Serratia marcescens by targeting the aminoglycoside N -acetyltransferase (AAC (6′)) enzyme, which inactivates aminoglycoside antibiotics through acetylation. Due to the absence of experimental structure, we constructed a homology model of aminoglycoside N (6′)-acetyltransferase (AAC (6′)) of S. marcescens using the atomic structure of aminoglycoside N -acetyltransferase AAC (6′)-Ib (PDB ID: 1V0C ) as a template. The stable architecture and integrity of the modelled AAC (6′) structure were analyzed through a 100 ns simulation. Structure-guided high-throughput screening of four small molecule databases (Binding, Life Chemicals, Zinc, and Toslab) resulted in the identification of potent inhibitors against AAC (6′). The hits obtained from screening were manually clustered, and the five hit molecules were shortlisted based on the docking score, which are observed in the range of −17.09 kcal/mol to −11.95 kcal/mol. These selected five molecules displayed acceptable pharmacological properties in ADME predictions. The binding free energy calculations, and molecular dynamics simulations of ligand bound AAC (6′) complexes represented higher affinity and stable binding. The selected molecules demonstrated stable binding with AAC (6′), indicating their strong potential to hamper the binding of aminoglycoside in the respective site. and thereby inhibit. This process mitigates enzyme mediated AAC (6′) activity on aminoglycosides and reverse the bactericidal function of aminoglycosides, and also this method could serve as a platform for the development of potential antimicrobials.

Development of a chemical scaffold for inhibiting nonribosomal peptide synthetases in live bacterial cells

Insights into the Substrate Tolerance of Enzymes Involved in the Nosiheptide Biosynthesis Pathway Based on Indolic Acid Moiety

Aminoacyl sulfonamide assembly in SB-203208 biosynthesis.

Family-wide analysis of aminoacyl-sulfamoyl-3-deazaadenosine analogues as inhibitors of aminoacyl-tRNA synthetases

Structural, biochemical and bioinformatic analyses of nonribosomal peptide synthetase adenylation domains

Biosynthetic Incorporation of Non-native Aryl Acid Building Blocks into Peptide Products Using Engineered Adenylation Domains

An Inhibitory Mechanism of AasS, an Exogenous Fatty Acid Scavenger: Implications for Re-Sensitization of FAS II Antimicrobials

Structure-activity relationship of pyrrolidine pentamine derivatives as inhibitors of the aminoglycoside 6'- -acetyltransferase type Ib

Characterization and Engineering of the Adenylation Domain of a NRPS-Like Protein: A Potential Biocatalyst for Aldehyde Generation

Expanding the substrate selectivity of the fimsbactin biosynthetic adenylation domain, FbsH

Structure–Activity Relationship of Pyrrolidine Pentamine Derivatives as Inhibitors of the Aminoglycoside 6′-N-Acetyltransferase Type Ib

Identification of a 2‐aminobenzimidazole scaffold that potentiates gram‐positive selective antibiotics against gram‐negative bacteria

An amphipathic peptide with antibiotic activity against multidrug-resistant Gram-negative bacteria

Designing potential lead compounds targeting aminoglycoside N (6′)-acetyltransferase in Serratia marcescens : A drug discovery strategy

Chemical Strategies for Visualizing and Analyzing Endogenous Nonribosomal Peptide Synthetase (NRPS) Megasynthetases

Acylated sulfonamide adenosines as potent inhibitors of the adenylate-forming enzyme superfamily

N-acyl-4-arylaminopiperidines: Design and synthesis of a potential antimicrobial scaffold

Alanyl-tRNA Synthetase-like Enzyme-Catalyzed Aminoacylation in Nucleoside Sulfamate Ascamycin Biosynthesis

The Mechanism of Inhibition of Mycobacterial (p)ppGpp Synthetases by a Synthetic Analog of Erogorgiaene

Aminoacyl-tRNA synthetase inhibitors as potent antibacterials.